Publicaciones en las que colabora con Mª Luz Martínez Chantar (10)

2024

  1. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

    Gut

2023

  1. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma

    Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005

2022

  1. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

  2. Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma

    Hepatology, Vol. 73, Núm. 6, pp. 2380-2396

2020

  1. Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: A machine-learning approach

    Cancers, Vol. 12, Núm. 6, pp. 1-30

2006

  1. S-Adenosylmethionine Regulates Cytoplasmic HuR Via AMP-Activated Kinase

    Gastroenterology, Vol. 131, Núm. 1, pp. 223-232

2004

  1. 5′-Methylthioadenosine Modulates the Inflammatory Response to Endotoxin in Mice and in Rat Hepatocytes

    Hepatology, Vol. 39, Núm. 4, pp. 1088-1098

2003

  1. L-methionine availability regulates expression of the methionine adenosyltransferase 2A gene in human hepatocarcinoma cells. Role of S-adenosylmethionine

    Journal of Biological Chemistry, Vol. 278, Núm. 22, pp. 19885-19890

2002

  1. S-Adenosylmethionine revisited: Its essential role in the regulation of liver function

    Alcohol